| 1. |
- Marto, João Pedro, et al.
(author)
-
Safety and Outcome of Revascularization Treatment in Patients With Acute Ischemic Stroke and COVID-19: The Global COVID-19 Stroke Registry.
- 2023
-
In: Neurology. - 1526-632X. ; 100:7
-
Journal article (peer-reviewed)abstract
- COVID-19-related inflammation, endothelial dysfunction, and coagulopathy may increase the bleeding risk and lower the efficacy of revascularization treatments in patients with acute ischemic stroke (AIS). We aimed to evaluate the safety and outcomes of revascularization treatments in patients with AIS and COVID-19.This was a retrospective multicenter cohort study of consecutive patients with AIS receiving intravenous thrombolysis (IVT) and/or endovascular treatment (EVT) between March 2020 and June 2021 tested for severe acute respiratory syndrome coronavirus 2 infection. With a doubly robust model combining propensity score weighting and multivariate regression, we studied the association of COVID-19 with intracranial bleeding complications and clinical outcomes. Subgroup analyses were performed according to treatment groups (IVT-only and EVT).Of a total of 15,128 included patients from 105 centers, 853 (5.6%) were diagnosed with COVID-19; of those, 5,848 (38.7%) patients received IVT-only and 9,280 (61.3%) EVT (with or without IVT). Patients with COVID-19 had a higher rate of symptomatic intracerebral hemorrhage (SICH) (adjusted OR 1.53; 95% CI 1.16-2.01), symptomatic subarachnoid hemorrhage (SSAH) (OR 1.80; 95% CI 1.20-2.69), SICH and/or SSAH combined (OR 1.56; 95% CI 1.23-1.99), 24-hour mortality (OR 2.47; 95% CI 1.58-3.86), and 3-month mortality (OR 1.88; 95% CI 1.52-2.33). Patients with COVID-19 also had an unfavorable shift in the distribution of the modified Rankin score at 3 months (OR 1.42; 95% CI 1.26-1.60).Patients with AIS and COVID-19 showed higher rates of intracranial bleeding complications and worse clinical outcomes after revascularization treatments than contemporaneous non-COVID-19 patients receiving treatment. Current available data do not allow direct conclusions to be drawn on the effectiveness of revascularization treatments in patients with COVID-19 or to establish different treatment recommendations in this subgroup of patients with ischemic stroke. Our findings can be taken into consideration for treatment decisions, patient monitoring, and establishing prognosis.The study was registered under ClinicalTrials.gov identifier NCT04895462.
|
|
| 2. |
- Czub, Joanna, et al.
(author)
-
CALIBRATION OF LOW ENERGY X-RAY EXPERIMENTAL SETUP WITH STRONGLY FILTERED BEAM USING DATA FROM A SEMICONDUCTOR AND A THERMOLUMINESCENT DETECTORS
- 2019
-
In: Radiation Protection Dosimetry. - : Oxford University Press (OUP). - 0144-8420 .- 1742-3406. ; 185:2, s. 266-273
-
Journal article (peer-reviewed)abstract
- The calibration of low energy X-ray experimental setup with strongly filtered beam dedicated to radiobiological research was performed using the absorbed dose calculated from the data collected by two types detectors. For this purpose a semiconductor (Amptek, USA) and a thermoluminescent (Institute of Nuclear Physics, Krakow, Poland) detectors were applied. The absorbed dose in water values estimated by both detectors are in good agreement.
|
|
| 3. |
- Czub, Joanna, et al.
(author)
-
Monte Carlo dosimetry using Fluka code and experimental dosimetry with Gafchromic EBT2 and XR-RV3 of self-built experimental setup for radiobiological studies with low-energy X-rays
- 2020
-
In: International Journal of Radiation Biology. - : Informa UK Limited. - 0955-3002 .- 1362-3095. ; 96:6, s. 718-733
-
Journal article (peer-reviewed)abstract
- Purpose: The aim of this research was to simulate self-built experimental setup for radiobiological research using X-ray diffraction C-tech tube and PW 3830 generator (PANalytical, Netherlands) and to calculate absorbed dose and to compare it with experimental dose measurements. The maximum X-ray energy was 60 keV.Materials and methods: Petri dish was specially adapted to hold biological cells during the irradiation process. Rotation of Petri dish ensured radiation homogeneity and effectiveness of rotation process was confirmed using EBT2 Gafchromic film. Monte Carlo simulation using Fluka 2011 2c.4 was used to model the setup and to calculate dose absorbed by live cells. The EBT2 and XR-RV3 Gafchromic films were used to estimate relative experimental absorbed dose.Results: The radiation homogeneity provided values with maximum deviation equal to +/- 3.5% from the average value and the absorbed dose rate was 0.9 Gy/min using simulation process and 1 Gy/min or 0.8 Gy/min using experimental methods (XR-RV3 and EBT2 Gafchromic film, respectively). All dose rate values show metrological compatibility.Conclusions: Influence of specially constructed Petri dish on absorbed dose was determined using simulations that showed that low-energy photons, emitted as characteristic line from borosilicate glass forming component of Petri dish, were source of increase in dose absorbed by cells. This experimental setup will be used to conduct radiobiological research.
|
|
